BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29626940)

  • 1. PET/MRI in Infection and Inflammation.
    Sollini M; Berchiolli R; Kirienko M; Rossi A; Glaudemans AWJM; Slart R; Erba PA
    Semin Nucl Med; 2018 May; 48(3):225-241. PubMed ID: 29626940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Molecular Imaging of Musculoskeletal Inflammation and Infection.
    Pawaskar A; Basu S; Jahangiri P; Alavi A
    PET Clin; 2019 Jan; 14(1):43-59. PubMed ID: 30420221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive advantage of PET/MRI.
    Jadvar H; Colletti PM
    Eur J Radiol; 2014 Jan; 83(1):84-94. PubMed ID: 23791129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial experience of MR/PET in a clinical cancer center.
    Partovi S; Robbin MR; Steinbach OC; Kohan A; Rubbert C; Vercher-Conejero JL; Kolthammer JA; Faulhaber P; Paspulati RM; Ros PR
    J Magn Reson Imaging; 2014 Apr; 39(4):768-80. PubMed ID: 24006287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/MRI in Pediatric Neuroimaging: Primer for Clinical Practice.
    Pedersen C; Aboian M; McConathy JE; Daldrup-Link H; Franceschi AM
    AJNR Am J Neuroradiol; 2022 Jul; 43(7):938-943. PubMed ID: 35512826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid PET/MR imaging: physics and technical considerations.
    Shah SN; Huang SS
    Abdom Imaging; 2015 Aug; 40(6):1358-65. PubMed ID: 25985965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM).
    Nensa F; Bamberg F; Rischpler C; Menezes L; Poeppel TD; la Fougère C; Beitzke D; Rasul S; Loewe C; Nikolaou K; Bucerius J; Kjaer A; Gutberlet M; Prakken NH; Vliegenthart R; Slart RHJA; Nekolla SG; Lassen ML; Pichler BJ; Schlosser T; Jacquier A; Quick HH; Schäfers M; Hacker M; ;
    Eur Radiol; 2018 Oct; 28(10):4086-4101. PubMed ID: 29717368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR/PET: a new challenge in hybrid imaging.
    Werner MK; Schmidt H; Schwenzer NF
    AJR Am J Roentgenol; 2012 Aug; 199(2):272-7. PubMed ID: 22826387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer.
    Platzek I
    PET Clin; 2016 Oct; 11(4):375-86. PubMed ID: 27593244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid MR-PET in Neuroimaging.
    Bisdas S; Lá Fougere C; Ernemann U
    Clin Neuroradiol; 2015 Oct; 25 Suppl 2():275-81. PubMed ID: 26227618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (18)F-Fluorodeoxyglucose PET/MR Imaging in Lymphoma.
    Platzek I
    PET Clin; 2016 Oct; 11(4):363-73. PubMed ID: 27593243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid ZTE/Dixon MR-based attenuation correction for quantitative uptake estimation of pelvic lesions in PET/MRI.
    Leynes AP; Yang J; Shanbhag DD; Kaushik SS; Seo Y; Hope TA; Wiesinger F; Larson PE
    Med Phys; 2017 Mar; 44(3):902-913. PubMed ID: 28112410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Status of Hybrid PET/MRI in Oncologic Imaging.
    Rosenkrantz AB; Friedman K; Chandarana H; Melsaether A; Moy L; Ding YS; Jhaveri K; Beltran L; Jain R
    AJR Am J Roentgenol; 2016 Jan; 206(1):162-72. PubMed ID: 26491894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/MR Imaging in Musculoskeletal Disorders.
    Andersen KF; Jensen KE; Loft A
    PET Clin; 2016 Oct; 11(4):453-63. PubMed ID: 27593249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/MR Imaging in Vascular Disease: Atherosclerosis and Inflammation.
    Ripa RS; Pedersen SF; Kjær A
    PET Clin; 2016 Oct; 11(4):479-88. PubMed ID: 27593251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/MRI in the Upper Abdomen.
    Gavra M; Syed R; Fraioli F; Afaq A; Bomanji J
    Semin Nucl Med; 2015 Jul; 45(4):282-92. PubMed ID: 26050656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.